Sugammadex Versus Neostigmine in Return to Intended Oncological Therapy After Gastrointestinal Cancer Surgery: A Retrospective Study.

Nicolas A Cortes-Mejia, Juan J Guerra-Londono, Tarikul Islam, Heather A Lillemoe, Gavin Ovsak, Lei Feng, Juan P Cata

Abstract read

In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicolas A Cortes-MejiaDepartment of Surgery, Wyckoff Heights Medical Center, New York, NY 11237, USA.ORCID 0000-0002-8164-6190

Juan J Guerra-LondonoDepartment of Anesthesiology, Pain Management, & Perioperative Medicine, Henry Ford Health System. Detroit, MI 48202, USA.ORCID 0000-0001-9546-0314

Tarikul IslamHouston McGovern Medical School, The University of Texas Health Science Center, Houston, TX 77030, USA.ORCID 0009-0009-3094-9982

Heather A LillemoeDepartment of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Gavin OvsakDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0003-3474-1301

Lei FengDepartment of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Juan P CataDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-3156-1682

Funding

Merck Sharp & Dome MISP 1014558

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

neostigminereturn-to-oncological therapysugammadex

Identifiers

PMID41228345

DOI10.3390/cancers17213553

PMCPMC12609655

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.